BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3911674)

  • 1. [Mechanisms of the mediated neutrophil reactivity to Escherichia coli peptidoglycan].
    Azov NA; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):66-9. PubMed ID: 3911674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivity to Staphylococcus aureus peptidoglycan in a neutrophil phagocytosis system].
    Boiarinova LV; Salina EV; Maianskaia IV; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Dec; (12):49-53. PubMed ID: 6666448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The manifestation of functional heterogeneity of the peptidoglycans in opsonophagocytic reactions].
    Maianskiĭ AN; Sibiriakova NI; Astaf'ev DG; Fokina IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):114-8. PubMed ID: 8059563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactivity to bacterial peptidoglycans in a phagocytosis system. The range of immunological specificity of Escherichia coli peptidoglycan].
    Azov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):74-7. PubMed ID: 2413663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The response of human lymphocytes to Staphylococcus aureus peptidoglycan in a system of opsonic cooperation].
    Maianskiĭ AN; Osipov OA; Astaf'ev DG
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):46-8. PubMed ID: 1789035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic defense to Staphylococcus epidermidis in the premature neonate.
    Fleer A; Gerards LJ; Aerts P; Westerdaal NA; Senders RC; van Dijk H; Verhoef J
    J Infect Dis; 1985 Nov; 152(5):930-7. PubMed ID: 4045255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic capacity of foal serum for the two neonatal pathogens Escherichia coli and Actinobacillus equuli.
    Gröndahl G; Sternberg S; Jensen-Waern M; Johannisson A
    Equine Vet J; 2001 Nov; 33(7):670-5. PubMed ID: 11770988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Direct IgG-mediated reactivity of human neutrophils to Corynebacterium diphtheriae peptidoglycan].
    Maianskiĭ AN; Shmeleva EA; Krylova NI; Maianskaia IV; Boiarinova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):99-101. PubMed ID: 6424364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
    Vreede RW; Marcelis JH; Verhoef J
    Infect Immun; 1986 Jun; 52(3):892-6. PubMed ID: 3519464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactivity to bacterial peptidoglycans in a phagocytosis system. 1. The range of immunological specificity of Staphylococcus aureus peptidoglycan].
    Maianskiĭ AN; Boiarinova LV; Azov NA; Maianskaia IV; Malysheva EF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):97-100. PubMed ID: 6207688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of different K antigens of Escherichia coli in phagocytosis by polymorphonuclear leukocytes.
    Verweij-Van Vught AM; Namavar F; Peerbooms PG; Sparrius M; Maclaren DM
    J Med Microbiol; 1984 Apr; 17(2):141-50. PubMed ID: 6142958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG.
    Lassiter HA; Christensen RD; Parker CJ
    J Infect Dis; 1989 Mar; 159(3):518-25. PubMed ID: 2644382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial mechanisms of antibody to mannose-sensitive pili of Escherichia coli.
    Weinstein R; Silverblatt FJ
    J Infect Dis; 1983 May; 147(5):882-9. PubMed ID: 6132951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.